BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33892849)

  • 21. Gene and Cellular Therapies for Leukodystrophies.
    Aerts-Kaya F; van Til NP
    Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, radiological and genetic aspects of leukodystrophies.
    László A; Elpeleg O; Horváth K; Jakobs C; Kóbor J; Gal A; Barsi P; Kelemen A; Saracz J; Svékus A; Tegzes A; Vörös E
    Ideggyogy Sz; 2010 Jul; 63(7-8):266-73. PubMed ID: 20812455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selected leukodystrophies.
    Powers JM; Rubio A
    Semin Pediatr Neurol; 1995 Sep; 2(3):200-10. PubMed ID: 9422247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurobiology of disease in children: leukodystrophies.
    Maria BL
    J Child Neurol; 2003 Sep; 18(9):577. PubMed ID: 14572134
    [No Abstract]   [Full Text] [Related]  

  • 25. Opening New Horizons in the Treatment of Childhood Onset Leukodystrophies.
    Schiller S; Henneke M; Gärtner J
    Neuropediatrics; 2019 Aug; 50(4):211-218. PubMed ID: 31113002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances and pitfalls of cell therapy in metabolic leukodystrophies.
    Miranda CO; Brites P; Mendes Sousa M; Teixeira CA
    Cell Transplant; 2013; 22(2):189-204. PubMed ID: 23006656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematopoietic Stem Cell Transplantation to Treat Leukodystrophies: Clinical Practice Guidelines from the Hunter's Hope Leukodystrophy Care Network.
    Page KM; Stenger EO; Connelly JA; Shyr D; West T; Wood S; Case L; Kester M; Shim S; Hammond L; Hammond M; Webb C; Biffi A; Bambach B; Fatemi A; Kurtzberg J
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):e363-e374. PubMed ID: 31499213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Childhood leukodystrophies: a clinical perspective.
    Kohlschütter A; Eichler F
    Expert Rev Neurother; 2011 Oct; 11(10):1485-96. PubMed ID: 21955203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
    Sessa M; Lorioli L; Fumagalli F; Acquati S; Redaelli D; Baldoli C; Canale S; Lopez ID; Morena F; Calabria A; Fiori R; Silvani P; Rancoita PM; Gabaldo M; Benedicenti F; Antonioli G; Assanelli A; Cicalese MP; Del Carro U; Sora MG; Martino S; Quattrini A; Montini E; Di Serio C; Ciceri F; Roncarolo MG; Aiuti A; Naldini L; Biffi A
    Lancet; 2016 Jul; 388(10043):476-87. PubMed ID: 27289174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scope and Burden of Non-Standard of Care Hematopoietic Stem Cell Transplantation in Pediatric Leukodystrophy Patients.
    Bonkowsky JL; Wilkes J; Shyr DC
    J Child Neurol; 2018 Dec; 33(14):882-887. PubMed ID: 30261790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic stem cell gene therapy in Hurler syndrome, globoid cell leukodystrophy, metachromatic leukodystrophy and X-adrenoleukodystrophy.
    Cartier N; Aubourg P
    Curr Opin Mol Ther; 2008 Oct; 10(5):471-8. PubMed ID: 18830923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene Therapy for Rare Central Nervous System Diseases Comes to Age.
    Aubourg P
    Endocr Dev; 2016; 30():141-6. PubMed ID: 26684481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Diagnosis of Leukodystrophy With Race and Ethnicity Among Pediatric and Adolescent Patients.
    Bonkowsky JL; Wilkes J; Bardsley T; Urbik VM; Stoddard G
    JAMA Netw Open; 2018 Nov; 1(7):e185031. PubMed ID: 30646379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukodystrophies: Indian scenario.
    Singhal BS
    Indian J Pediatr; 2005 Apr; 72(4):315-8. PubMed ID: 15876760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies.
    van den Broek BTA; Page K; Paviglianiti A; Hol J; Allewelt H; Volt F; Michel G; Diaz MA; Bordon V; O'Brien T; Shaw PJ; Kenzey C; Al-Seraihy A; van Hasselt PM; Gennery AR; Gluckman E; Rocha V; Ruggeri A; Kurtzberg J; Boelens JJ
    Blood Adv; 2018 Jan; 2(1):49-60. PubMed ID: 29344584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI appearances of metachromatic leukodystrophy.
    Faerber EN; Melvin J; Smergel EM
    Pediatr Radiol; 1999 Sep; 29(9):669-72. PubMed ID: 10460327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukodystrophies.
    Adang L
    Continuum (Minneap Minn); 2022 Aug; 28(4):1194-1216. PubMed ID: 35938662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Geographic and Specialty Access Disparities in US Pediatric Leukodystrophy Diagnosis.
    Grineski S; Morales DX; Collins T; Wilkes J; Bonkowsky JL
    J Pediatr; 2020 May; 220():193-199. PubMed ID: 32143930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysosomal leukodystrophies: Krabbe disease and metachromatic leukodystrophy.
    Kohlschütter A
    Handb Clin Neurol; 2013; 113():1611-8. PubMed ID: 23622382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune response in leukodystrophies.
    Eichler F; Van Haren K
    Pediatr Neurol; 2007 Oct; 37(4):235-44. PubMed ID: 17903666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.